Overview Fundamentals API Earnings EOD API Sample Code Pricing

Checkpoint Therapeutics Inc (CKPT NASDAQ) stock market data APIs

$2.26 -0.09(-3.8%) as of July 12, 2024
Price chart is built with Anychart

Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is Cosibelimab, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignancies and solid tumors. It is developing Olafertinib, which is in Phase 3 clinical trials for the treatment of adult patients with metastatic non-small cell lung cancer; CK-103 for the treatment of various advanced and metastatic solid tumor cancers; and Anti-Carbonic Anhydrase IX (CAIX) antibody, a product candidate in preclinical trials to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has licensing and collaboration agreements with Adimab, LLC for the development of Cosibelimab; NeuPharma, Inc., to develop and commercialize Olafertinib; and Jubilant Biosys Limited for the development and commercialization of novel compounds that inhibit BET bromodomains. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

Checkpoint Therapeutics Inc Financial Data Overview

2.35
2.26
-
2.35
2.25
1.3-3.62
89 489 K
37 380 K
68 000
-0.33
1.252
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CKPT',
Type: 'Common Stock',
Name: 'Checkpoint Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00F5TPW72',
ISIN: NULL,
CUSIP: NULL,
CIK: '1651407',
EmployerIdNumber: '47-2568632',
FiscalYearEnd: 'December',
IPODate: '2017-06-26',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Checkpoint Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 68 000
  • EBITDA 0
  • Earnings Per Share -2.61
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Checkpoint Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-10
  • EPS/Forecast -0.27

Get Checkpoint Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com